Compositions and methods of treating muscle dystrophy

Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating muscle dystrophy (DM1).

Saved in:
Bibliographic Details
Main Authors SHI, YUNYU, HOOD, MICHAEL DAVID, BURKE, ROB, DARIMONT, BEATRICE DIANA, DOPPALAPUDI, VENKATA RAMANA, MALECOVA, BARBORA, COCHRAN, MICHAEL CARAMIAN, MARELIUS, GULIN ERDOGAN
Format Patent
LanguageChinese
English
Published 16.01.2022
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating muscle dystrophy (DM1).
Bibliography:Application Number: TW202110110999